ArticleJournal of clinical medicine2023

Substance P and Neurokinin-1 Receptor System in Thyroid Cancer: Potential Targets for New Molecular Therapies.

Inmaculada Isorna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.